Anti-NUDCD3 monoclonal antibody

Pre-made anti-NUDCD3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NUDCD3/NUDCD3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2632-Ab-1/ GM-Tg-hg-IP2632-Ab-2Anti-Human NUDCD3 monoclonal antibodyHuman
GM-Tg-rg-IP2632-Ab-1/ GM-Tg-rg-IP2632-Ab-2Anti-Rat NUDCD3 monoclonal antibodyRat
GM-Tg-mg-IP2632-Ab-1/ GM-Tg-mg-IP2632-Ab-2Anti-Mouse NUDCD3 monoclonal antibodyMouse
GM-Tg-cynog-IP2632-Ab-1/ GM-Tg-cynog-IP2632-Ab-2Anti-Cynomolgus/ Rhesus macaque NUDCD3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2632-Ab-1/ GM-Tg-felg-IP2632-Ab-2Anti-Feline NUDCD3 monoclonal antibodyFeline
GM-Tg-cang-IP2632-Ab-1/ GM-Tg-cang-IP2632-Ab-2Anti-Canine NUDCD3 monoclonal antibodyCanine
GM-Tg-bovg-IP2632-Ab-1/ GM-Tg-bovg-IP2632-Ab-2Anti-Bovine NUDCD3 monoclonal antibodyBovine
GM-Tg-equg-IP2632-Ab-1/ GM-Tg-equg-IP2632-Ab-2Anti-Equine NUDCD3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2632-Ab-1/ GM-Tg-hg-IP2632-Ab-2; GM-Tg-rg-IP2632-Ab-1/ GM-Tg-rg-IP2632-Ab-2;
GM-Tg-mg-IP2632-Ab-1/ GM-Tg-mg-IP2632-Ab-2; GM-Tg-cynog-IP2632-Ab-1/ GM-Tg-cynog-IP2632-Ab-2;
GM-Tg-felg-IP2632-Ab-1/ GM-Tg-felg-IP2632-Ab-2; GM-Tg-cang-IP2632-Ab-1/ GM-Tg-cang-IP2632-Ab-2;
GM-Tg-bovg-IP2632-Ab-1/ GM-Tg-bovg-IP2632-Ab-2; GM-Tg-equg-IP2632-Ab-1/ GM-Tg-equg-IP2632-Ab-2
Products NameAnti-NUDCD3 monoclonal antibody
Formatmab
Target NameNUDCD3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NUDCD3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2632-Ag-1Recombinant multi-species NUDC3/ NUDCD3/ NudCL protein


    Target information

    Target IDGM-IP2632
    Target NameNUDCD3
    Gene ID23386,209586,100125378,699353,608096,111559463,533678,100065072
    Gene Symbol and SynonymsmKIAA1068,NUDCD3,NudCL
    Uniprot AccessionQ8IVD9
    Uniprot Entry NameNUDC3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000015676
    Target ClassificationN/A

    The target: NUDCD3, gene name: NUDCD3, also named as NudCL. The product of this gene functions to maintain the stability of dynein intermediate chain. Depletion of this gene product results in aggregation and degradation of dynein intermediate chain, mislocalization of the dynein complex from kinetochores, spindle microtubules, and spindle poles, and loss of gamma-tubulin from spindle poles. The protein localizes to the Golgi apparatus during interphase, and levels of the protein increase after the G1/S transition. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.